EphA2 Is a Neutrophil Receptor for Candida albicans that Stimulates Antifungal Activity during Oropharyngeal Infection
Marc Swidergall(Los Angeles Harbor College), Scott G. Filler(University of California, Los Angeles), Norma V. Solis(UCLA Medical Center), Eric Pearlman(University of California, San Francisco), Quynh T. Phan(Harbor–UCLA Medical Center), Michaela Marshall(University of California, Irvine), Zeping Wang(Washington State University), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases)
Cited by 73
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Guidelines for Treatment of Candidiasis
|Clinical Infectious Diseases|2004|1.4k
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453